Clinical studies in the development of new anticancer agents exhibiting growth inhibition in models: facing the challenge of a proper study design

Ferry Eskens; Jaap Verweij

doi:10.1016/S1040-8428(00)00055-X

Clinical studies in the development of new anticancer agents exhibiting growth inhibition in models: facing the challenge of a proper study design

Ferry Eskens
, Jaap Verweij

Medical Oncology

Research output: Contribution to journal › Article › Academic › peer-review

25 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	83-88
Number of pages	6
Journal	Crc Critical Reviews in Oncology/Hematology
Volume	34
DOIs	https://doi.org/10.1016/S1040-8428(00)00055-X
Publication status	Published - 2000

Research programs

EMC MM-03-86-08

Access to Document

10.1016/S1040-8428(00)00055-X

http://hdl.handle.net/1765/67716

Cite this

@article{85fdb556c07e4ddc81e3138f8f552506,

title = "Clinical studies in the development of new anticancer agents exhibiting growth inhibition in models: facing the challenge of a proper study design",

author = "Ferry Eskens and Jaap Verweij",

year = "2000",

doi = "10.1016/S1040-8428(00)00055-X",

language = "Undefined/Unknown",

volume = "34",

pages = "83--88",

}

TY - JOUR

T1 - Clinical studies in the development of new anticancer agents exhibiting growth inhibition in models: facing the challenge of a proper study design

AU - Eskens, Ferry

AU - Verweij, Jaap

PY - 2000

Y1 - 2000

U2 - 10.1016/S1040-8428(00)00055-X

DO - 10.1016/S1040-8428(00)00055-X

M3 - Article

SN - 0737-9587

VL - 34

SP - 83

EP - 88

JO - Crc Critical Reviews in Oncology/Hematology

JF - Crc Critical Reviews in Oncology/Hematology

ER -